Dexamethasone Therapy in VLBW Infants at Risk of CLD (Dexamethasone)
Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD)
Sponsor: NICHD Neonatal Research Network
A PHASE3 clinical study on Bronchopulmonary Dysplasia and Infant, Low Birth Weight, this trial is completed. The trial is conducted by NICHD Neonatal Research Network and has accumulated 8 data snapshots since 1992. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Sep 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .